Insulin release and K+-induced depolarization in mouse pancreatic beta-cells

Desensitization of the insulin-secreting beta cell

In human diabetes, inherent impaired insulin secretion can be exacerbated by desensitization of the beta cell by chronic hyperglycemia. Interest in this phenomenon has generated extensive studies in genetic or experimentally induced diabetes in animals and in fully in vitro systems, with often conflicting results. In general, although chronic glucose causes decreased beta-cell response to this carbohydrate, basal response and response to alternate stimulating agents are enhanced. Glucose-stimulated insulin synthesis can be increased or decreased depending on the system studied. Using a two-compartment beta-cell model of phasic insulin secretion, a unifying hypothesis is described which can explain some of the apparent conflicting data. This hypothesis suggests that glucose-desensitization is caused by an impairment in stimulation of a hypothetical potentiator singularly responsible for: 1) some of the characteristic phases of insulin secretion; 2) basal release; 3) potentiation of non-glucose stimulators; and 4) apparent "recovery" from desensitization. Review of some of the pathways that regulate insulin secretion suggest that phosphoinositol metabolism and protein kinase-C production are regulated similarly to the theoretical potentiator and their impairment is a major contributor to glucose desensitization in the beta cell.

Glucose modulation of spike activity independently from changes in slow waves of membrane potential in mouse B-cells

In mouse B-cells glucose induces a typical electrical activity consisting of slow waves of the membrane potential with spikes superimposed on the plateau. As the concentration of glucose is raised the number of spikes per minute increases. However, this increase could simply be due to the concomitant lengthening of the slow waves. We thus investigated whether glucose can influence spike activity when no slow waves occur. Persistent depolarization to the plateau potential was achieved at 3 mM glucose by tolbutamide or at 10 mM glucose by low Ca2+, by arginine or by ouabain. Under all these conditions, raising the concentration of glucose increased the spike frequency without changing the plateau potential. Similar effects were produced by tolbutamide which does not affect B-cell metabolism but directly blocks K+-ATP channels. The spike frequency could also be increased by arginine, which, however, consistently depolarized the membrane. In conclusion, spike activity in B-cells can be influenced by glucose independently from changes in slow wave duration. This indicates that some K+-ATP channels, a target for both glucose and tolbutamide, are still open when the membrane is depolarized at the plateau, or that these two agents share another yet unidentified target involved in spike generation.